<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>LIANG_SILENCED_BY_METHYLATION_DN</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            LIANG_SILENCED_BY_METHYLATION_DN
        </div>
        <div class="card-body">
                <p>Hypermethylation of the promoters of cancer-related genes is often associated with their inactivation during tumorigenesis. Several preclinical and clinical trials have been developed to use DNA methylation inhibitors, such as 5-aza-2&#39;-deoxycytidine (5-Aza-CdR) in attempts to reactivate silenced genes in human cancers. We used high-density oligonucleotide gene expression microarrays to examine the effects of 5-Aza-CdR treatment on human fibroblast cells (LD419) and a human bladder tumor cell line (T24). Data obtained 8 days after recovery from 5-Aza-CdR treatment showed that more genes were induced in tumorigenic cells (61 genes induced; &gt;or=4-fold) than nontumorigenic cells (34 genes induced; &gt;or= 4-fold). Approximately 60% of induced genes did not have CpG islands within their 5&#39; regions, suggesting that some genes activated by 5-Aza-CdR may not result from the direct inhibition of promoter methylation. Interestingly, a high percentage of genes activated in both cell types belonged to the IFN signaling pathway, confirming data from other tumor cell types.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M6302">M6302</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:2305">ncbigene:2305</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:11013">ncbigene:11013</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1033">ncbigene:1033</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4288">ncbigene:4288</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6387">ncbigene:6387</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3148">ncbigene:3148</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4171">ncbigene:4171</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2146">ncbigene:2146</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3832">ncbigene:3832</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:890">ncbigene:890</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9768">ncbigene:9768</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M6302&#39;, name=&#39;LIANG_SILENCED_BY_METHYLATION_DN&#39;), definition=&#34;Hypermethylation of the promoters of cancer-related genes is often associated with their inactivation during tumorigenesis. Several preclinical and clinical trials have been developed to use DNA methylation inhibitors, such as 5-aza-2&#39;-deoxycytidine (5-Aza-CdR) in attempts to reactivate silenced genes in human cancers. We used high-density oligonucleotide gene expression microarrays to examine the effects of 5-Aza-CdR treatment on human fibroblast cells (LD419) and a human bladder tumor cell line (T24). Data obtained 8 days after recovery from 5-Aza-CdR treatment showed that more genes were induced in tumorigenic cells (61 genes induced; &gt;or=4-fold) than nontumorigenic cells (34 genes induced; &gt;or= 4-fold). Approximately 60% of induced genes did not have CpG islands within their 5&#39; regions, suggesting that some genes activated by 5-Aza-CdR may not result from the direct inhibition of promoter methylation. Interestingly, a high percentage of genes activated in both cell types belonged to the IFN signaling pathway, confirming data from other tumor cell types.&#34;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;11861364&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2305&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;11013&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1033&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4288&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6387&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3148&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4171&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2146&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3832&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;890&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9768&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;John Newman&#39;], &#39;exact_source&#39;: [&#39;Table 1&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>